|
|
||||||||
Department of Medicine, University of North Carolina, Chapel Hill 27514.
1. Employing a primary cell culture system and intracellular microelectrodes, we quantitated and compared the Na+ and Cl- pathways in apical membranes of normal and cystic fibrosis (CF) human airway epithelia. 2. Like the transepithelial difference (PD) in situ, the PD of CF epithelia in culture (-27 +/- 4 mV, mean +/- S.E.M.; n = 28) exceeded the PD of normal epithelia (-10 +/- 1 mV; n = 22). The raised PD principally reflected an increase in the rate of active transport (equivalent short circuit, Ieq) for CF epithelia (61 +/- 9 microA cm-2) as compared with normal epithelia (23 +/- 3 microA cm-2). No significant differences in transepithelial resistance were detected. 3. As indicated by ion replacement studies (gluconate for Cl-), the apical membrane of normal cells exhibits an apical membrane Cl- conductance (GCl) that can be activated by isoprenaline. CF cells do not exhibit an apical membrane GCl, nor can a GCl be activated by isoprenaline. 4. CF cells exhibited a larger amiloride-sensitive Ieq and amiloride-sensitive apical membrane conductance (GNa) than normal cells. Further, the amiloride-sensitive Ieq was increased by isoprenaline in CF but not normal airway epithelia. 5. Equivalent circuit analysis yielded evidence for a more positive electromotive force (EMF) across the apical membrane and a more negative EMF across the basolateral membrane of CF cells as compared with normal cells. Baseline resistances of the apical (Ra) and basolateral (Rb) membranes did not differ for normal and CF cells. 6. Estimates of the resistance of the paracellular path to ion flow (Rs) by equivalent circuit analysis or ion substitution detected no differences in Rs between CF and normal cells. 7. We conclude that abnormalities in both cellular Cl- permeability (reduced) and Na+ permeability (increased) are characteristic of the cultured CF respiratory epithelial cell. These data suggest that a defect in the regulation of apical membrane permeabilities is a central feature of this disease.
This article has been cited by other articles:
![]() |
A. P. Albert, A. M. Woollhead, O. J. Mace, and D. L. Baines AICAR decreases the activity of two distinct amiloride-sensitive Na+-permeable channels in H441 human lung epithelial cell monolayers Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L837 - L848. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Mace, A. M. Woollhead, and D. L. Baines AICAR activates AMPK and alters PIP2 association with the epithelial sodium channel ENaC to inhibit Na+ transport in H441 lung epithelial cells J. Physiol., September 15, 2008; 586(18): 4541 - 4557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hirsh, J. Zhang, A. Zamurs, J. Fleegle, W. R. Thelin, R. A. Caldwell, J. R. Sabater, W. M. Abraham, M. Donowitz, B. Cha, et al. Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pedemonte, E. Caci, E. Sondo, A. Caputo, K. Rhoden, U. Pfeffer, M. Di Candia, R. Bandettini, R. Ravazzolo, O. Zegarra-Moran, et al. Thiocyanate Transport in Resting and IL-4-Stimulated Human Bronchial Epithelial Cells: Role of Pendrin and Anion Channels J. Immunol., April 15, 2007; 178(8): 5144 - 5153. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Su, Q. Li, K. Shrestha, E. Cormet-Boyaka, L. Chen, P. R. Smith, E. J. Sorscher, D. J. Benos, S. Matalon, and H.-L. Ji Interregulation of Proton-gated Na+ Channel 3 and Cystic Fibrosis Transmembrane Conductance Regulator J. Biol. Chem., December 1, 2006; 281(48): 36960 - 36968. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Grubb, T. D. Rogers, P. C. Diggs, R. C. Boucher, and L. E. Ostrowski Culture of murine nasal epithelia: model for cystic fibrosis Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L270 - L277. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hollande, C. Salvador-Cartier, L. Alvarez, and M. Fanjul Expression of a Wild-type CFTR Maintains the Integrity of the Biosynthetic/Secretory Pathway in Human Cystic Fibrosis Pancreatic Duct Cells J. Histochem. Cytochem., December 1, 2005; 53(12): 1539 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bachhuber, J. Konig, T. Voelcker, B. Murle, R. Schreiber, and K. Kunzelmann Cl- Interference with the Epithelial Na+ Channel ENaC J. Biol. Chem., September 9, 2005; 280(36): 31587 - 31594. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Snyder, D. R. Olson, R. Kabra, R. Zhou, and J. C. Steines cAMP and Serum and Glucocorticoid-inducible Kinase (SGK) Regulate the Epithelial Na+ Channel through Convergent Phosphorylation of Nedd4-2 J. Biol. Chem., October 29, 2004; 279(44): 45753 - 45758. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Snyder, J. C. Steines, and D. R. Olson Relative Contribution of Nedd4 and Nedd4-2 to ENaC Regulation in Epithelia Determined by RNA Interference J. Biol. Chem., February 6, 2004; 279(6): 5042 - 5046. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Zeitlin, M. P. Boyle, W. B. Guggino, and L. Molina A Phase I Trial of Intranasal Moli1901 for Cystic Fibrosis Chest, January 1, 2004; 125(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Ji, B. Jovov, J. Fu, L. R. Bishop, H. C. Mebane, C. M. Fuller, B. A. Stanton, and D. J. Benos Up-regulation of Acid-gated Na+ Channels (ASICs) by Cystic Fibrosis Transmembrane Conductance Regulator Co-expression in Xenopus Oocytes J. Biol. Chem., March 1, 2002; 277(10): 8395 - 8405. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunzelmann and M. Mall Electrolyte Transport in the Mammalian Colon: Mechanisms and Implications for Disease Physiol Rev, January 1, 2002; 82(1): 245 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bridges, B. B. Newton, J. M. Pilewski, D. C. Devor, C. T. Poll, and R. L. Hall Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437 Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L16 - L23. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.C. Rodgers and A.J. Knox Pharmacological treatment of the biochemical defect in cystic fibrosis airways Eur. Respir. J., June 1, 2001; 17(6): 1314 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takacs-Jarrett, W. E. Sweeney, E. D. Avner, and C. U. Cotton Generation and phenotype of cell lines derived from CF and non-CF mice that carry the H-2Kb-tsA58 transgene Am J Physiol Cell Physiol, January 1, 2001; 280(1): C228 - C236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mall, A. Wissner, T. Gonska, D. Calenborn, J. Kuehr, M. Brandis, and K. Kunzelmann Inhibition of Amiloride-Sensitive Epithelial Na+ Absorption by Extracellular Nucleotides in Human Normal and Cystic Fibrosis Airways Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 755 - 761. [Abstract] [Full Text] |
||||
![]() |
M. Mall, A. Wissner, H. H. Seydewitz, J. Kuehr, M. Brandis, R. Greger, and K. Kunzelmann Defective cholinergic Cl- secretion and detection of K+ secretion in rectal biopsies from cystic fibrosis patients Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G617 - G624. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Pedersen, N.-H. Holstein-Rathlou, P. L. Larsen, K. Qvortrup, and O. Frederiksen Fluid absorption related to ion transport in human airway epithelial spheroids Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1096 - L1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mall, M. Bleich, J. Kuehr, M. Brandis, R. Greger, and K. Kunzelmann CFTR-mediated inhibition of epithelial Na+ conductance in human colon is defective in cystic fibrosis Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G709 - G716. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schreiber, A. Hopf, M. Mall, R. Greger, and K. Kunzelmann The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel PNAS, April 27, 1999; 96(9): 5310 - 5315. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schreiber, R. Nitschke, R. Greger, and K. Kunzelmann The Cystic Fibrosis Transmembrane Conductance Regulator Activates Aquaporin 3 in Airway Epithelial Cells J. Biol. Chem., April 23, 1999; 274(17): 11811 - 11816. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Grubb and R. C. Boucher Effect of in vivo corticosteroids on Na+ transport across airway epithelia Am J Physiol Cell Physiol, July 1, 1998; 275(1): C303 - C308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. ZAHM, C. GALABERT, A. CHAFFIN, J.-P. CHAZALETTE, C. GROSSKOPF, and E. PUCHELLE Improvement of Cystic Fibrosis Airway Mucus Transportability by Recombinant Human DNase Is Related to Changes in Phospholipid Profile Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1779 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. HOFMANN, M. J. STUTTS, A. ZIERSCH, C. RUCKES, W. M. WEBER, M. R. KNOWLES, H. LINDEMANN, and R. C. BOUCHER Effects of Topically Delivered Benzamil and Amiloride on Nasal Potential Difference in Cystic Fibrosis Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1844 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Cantiello, G. R. Jackson Jr., C. F. Grosman, A. G. Prat, S. C. Borkan, Y. Wang, I. L. Reisin, C. R. O'Riordan, and D. A. Ausiello Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator Am J Physiol Cell Physiol, March 1, 1998; 274(3): C799 - C809. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Ling, J. B. Zuckerman, C. Lin, B. J. Harte, K. A. McNulty, P. R. Smith, L. M. Gomez, R. T. Worrell, D. C. Eaton, and T. R. Kleyman Expression of the Cystic Fibrosis Phenotype in a Renal Amphibian Epithelial Cell Line J. Biol. Chem., January 3, 1997; 272(1): 594 - 600. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |